Filings Radar

SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.

Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.

Ionetix Corp / DE /

8-K Other material confidence 75% filed 2026-05-26 Item 7.01

The Company announced FDA approval of its ANDA for Gallium Ga-68 gozetotide (PSMA-11), a significant regulatory milestone for a pharmaceutical company. While this is a material event affecting investor assessment of the registrant's product pipeline and commercial prospects, it does not fit neatly into the predefined taxonomy categories (not an earnings release, M&A activity, impairment, or other specific event types). This regulatory approval is best classified as "other_material" given its clear materiality to a pharmaceutical company's business prospects.

View raw filing on EDGAR →

Spectral AI, Inc. (MDAIW)

8-K Other material confidence 75% filed 2026-05-26

Spectral AI announced on May 26, 2026 that the FDA granted De Novo Classification for its DeepView® System, authorizing commercial distribution in the United States. This is a material regulatory milestone that enables the company to commercialize a key product, but it does not fit neatly into the standard 8-K event taxonomy (not an earnings release, M&A activity, executive change, impairment, or other specifically enumerated category). The De Novo pathway is a significant regulatory achievement for a medical device company that would affect investor assessment of commercialization prospects.

View raw filing on EDGAR →

Quantum Cyber N.V. (QUCY)

8-K Other material confidence 72% filed 2026-05-26 Item 8.01

This Item 8.01 disclosure describes a comprehensive business overview and strategic pivot for Quantum Cyber N.V., including a name change from "Mainz Biomed N.V." to "Quantum Cyber N.V." in April 2026 and formation of a U.S. subsidiary (Quantum Drones Corporation) in May 2026. The filing details a fundamental shift from a pharmaceutical genomics company to an AI and quantum computing-focused autonomous vehicle platform developer. While the prose does not fit neatly into the specific event categories (no M&A completion, no earnings release, no executive change, no covenant breach), the material business transformation and strategic repositioning would affect a reasonable investor's assessment of the registrant's operations, market focus, and risk profile.

View raw filing on EDGAR →

Neuphoria Therapeutics Inc. (NEUP)

8-K Other material confidence 72% filed 2026-05-26

Neuphoria received a material revenue distribution of AUD $1.416M (approximately USD ~$950K) from its participation in the Cancer Therapeutics CRC related to Pfizer's KAT6 program milestone. The company also disclosed it is eligible to receive approximately 4.65% of future milestone payments estimated at USD $460M total across all parties. While this is a revenue/milestone event, it does not fit cleanly into earnings_release (no quarterly/annual results disclosure) or other standard categories, making other_material the most appropriate classification for this passive participation in a third-party licensing arrangement with contingent future payments.

View raw filing on EDGAR →

20/20 Biolabs, Inc. (AIDX)

8-K Other material confidence 65% filed 2026-05-26 Item 3.03

The Board adopted Amendment No. 1 to reduce the quorum requirement for stockholder meetings from a majority to one-third of shares outstanding, materially modifying stockholder rights and governance dynamics.

View raw filing on EDGAR →

Rising Dragon Acquisition Corp. (RDACU)

8-K Other material confidence 68% filed 2026-05-26 Item 2.03

Rising Dragon Acquisition Corp. issued two $50,000 unsecured promissory notes to its sponsor (Aurora Beacon LLC) and a merger counterparty designee (SZG Limited) on May 15, 2026, to fund the trust account and extend the business combination deadline to June 15, 2026. The notes are convertible into IPO units at $10.00 per unit, combining debt and equity financing elements in support of the SPAC's active merger negotiations.

View raw filing on EDGAR →

Federal Home Loan Bank of Cincinnati

8-K Other material confidence 75% filed 2026-05-26 Item 2.03

This Item 2.03 disclosure reports the issuance of Consolidated Bonds and Consolidated Discount Notes by the Federal Home Loan Bank of Cincinnati. Schedule A details three specific bond issuances totaling approximately $575.5 million in principal amount across trade dates in May 2026. While Item 2.03 is the designated item for creation of direct financial obligations, the event does not fit neatly into the more specific taxonomy categories (covenant_breach, dilutive_issuance, etc.). The issuance of debt securities is material to investors assessing the registrant's capital structure and financial obligations, warranting classification as other_material.

View raw filing on EDGAR →

Federal Home Loan Bank of Boston

8-K Other material confidence 65% filed 2026-05-26 Item 2.03

This Item 2.03 disclosure reports the issuance of consolidated obligations (debt securities) totaling approximately $725 million across four tranches on trade date 5/21/2026. While Item 2.03 is nominally for "Creation of a Direct Financial Obligation," the filing itself notes that "although certain aggregated issuances of consolidated obligations are material to the Bank, we have not made a judgment as to the materiality of any particular consolidated obligation or obligations." The disclosure is routine debt issuance reporting for a Federal Home Loan Bank, which regularly issues consolidated obligations as its primary funding mechanism. This does not fit cleanly into covenant_breach (no breach alleged), ma_activity (no acquisition/merger), or other specific event types—it is a material debt issuance that warrants classification as other_material rather than forcing it into an ill-fitting category.

View raw filing on EDGAR →

Federal Home Loan Bank of Indianapolis

8-K Other material confidence 65% filed 2026-05-26 Item 2.03

The filing discloses the Federal Home Loan Bank of Indianapolis becoming the primary obligor on consolidated obligation bonds totaling $100 million across four tranches with maturities ranging from 2030 to 2041. While Item 2.03 is technically about creation of direct financial obligations, this disclosure does not fit cleanly into the covenant_breach category (no breach alleged) and the bonds appear to be routine consolidated obligations issued by the FHLBank system rather than a triggering event of financial distress. The materiality lies in the new debt obligation itself, but the event type taxonomy lacks a dedicated "debt issuance" category, making "other_material" the most appropriate classification for this material but routine debt financing activity.

View raw filing on EDGAR →

Federal Home Loan Bank of Dallas

8-K Other material confidence 72% filed 2026-05-26 Item 2.03

This 8-K Item 2.03 discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds totaling $500 million ($250M + $250M) by the Federal Home Loan Bank of Dallas. While the filing explicitly states "the Bank has not made a judgment as to the materiality of these consolidated obligation bonds," the issuance of half a billion dollars in debt securities represents a material creation of financial obligations that would affect a reasonable investor's assessment of the registrant's capital structure and leverage. The event does not fit neatly into the more specific taxonomy categories (it is not a covenant breach, going concern, or impairment), making "other_material" the most appropriate classification for this routine but material debt issuance disclosure.

View raw filing on EDGAR →

Genprex, Inc. (GNPX)

8-K Other material confidence 72% filed 2026-05-26 Item 8.01

Genprex announced publication of a peer-reviewed abstract at the 2026 ASCO Annual Meeting presenting positive clinical data from its Acclaim trials showing that high Trop-2 and low PTEN biomarkers correlate with prolonged PFS in NSCLC patients receiving Reqorsa gene therapy. While this is clinical validation of a lead drug candidate and biomarker discovery that would be material to investors assessing development progress, it does not fit neatly into the standard 8-K taxonomy—it is neither an earnings release, M&A activity, executive change, restatement, nor other specifically enumerated event. The disclosure represents material clinical progress and biomarker validation that would affect a reasonable investor's assessment of the company's pipeline advancement.

View raw filing on EDGAR →

DROPBOX, INC. (DBX)

8-K Other material confidence 65% filed 2026-05-26 Item 7.01

Dropbox provided updated guidance for Q2 2026 and FY 2026 financial results, indicating performance expected to be in-line with or above previously provided guidance ranges, along with a blog post addressing matters related to the leadership transitions.

View raw filing on EDGAR →

Agassi Sports Entertainment Corp. (AASP)

8-K Other material confidence 75% filed 2026-05-26 Item 7.01

The Company announced filing an application to seek listing on the Nasdaq Capital Market. While this is a significant corporate development that would materially affect investor assessment of the registrant's status and market access, it does not fit neatly into the delisting_risk category (which addresses delisting notices or failures to maintain listing standards). The announcement of a listing application is a material event but falls outside the more specific taxonomy categories, making other_material the most appropriate classification.

View raw filing on EDGAR →

Groupon, Inc. (GRPN)

8-K Other material confidence 75% filed 2026-05-26 Item 2.05

The Board approved a restructuring plan involving up to 400 workforce reductions globally, with estimated pre-tax charges of $7–$13 million and expected annualized cost savings of $20–$25 million. The restructuring is tied to the company's AI-native strategy and includes additional material cost-reduction actions under evaluation, with upward revision of Full Year Adjusted EBITDA guidance.

View raw filing on EDGAR →

Worksport Ltd (WKSP)

8-K Other material confidence 65% filed 2026-05-26

The filing discloses that Worksport Ltd. secured a U.S. patent for an "industry-first" Zerofrost Heat Pump through its subsidiary Terravis Energy. While this represents a material intellectual property achievement that could affect investor assessment of the company's competitive position and product pipeline, it does not fit neatly into the standard 8-K event taxonomy (not earnings, M&A, executive changes, impairment, litigation, or other defined categories). The patent grant is disclosed via Item 7.01 (Regulation FD Disclosure) rather than a dedicated Item, suggesting the company classified it as a material event outside standard categories.

View raw filing on EDGAR →

Cocrystal Pharma, Inc. (COCP)

8-K Other material confidence 55% filed 2026-05-26

The filing discloses a press release regarding "novel direct-acting antivirals" under Item 7.01 (Regulation FD Disclosure). Without access to the actual press release content (Exhibit 99.1), the materiality and specific event type cannot be definitively determined. The disclosure could relate to clinical trial results, product development milestones, or other significant pharmaceutical developments. Given the uncertainty about the substantive content and the lack of a more specific event category that clearly fits, "other_material" is the most appropriate classification, with moderate confidence reflecting the information gap.

View raw filing on EDGAR →

Motorsport Games Inc. (MSGM)

8-K Other material confidence 75% filed 2026-05-26

The filing discloses amendments to the Certificate of Incorporation and Bylaws that materially restrict stockholder rights. Specifically, Section C of Article VII eliminates stockholders' ability to take action by written consent and requires all stockholder actions to occur at duly called meetings. This is a material governance change that affects the rights and protections of security holders, though it does not fit neatly into the standard event taxonomy categories.

View raw filing on EDGAR →

Lipocine Inc. (LPCN)

8-K Other material confidence 72% filed 2026-05-26

Lipocine disclosed presentation of Phase 3 clinical trial results for LPCN 1154 (oral brexanolone) for postpartum depression treatment at the ASCP Annual Meeting on May 26, 2026. While this represents material clinical progress for a biopharmaceutical company's lead candidate, it does not fit neatly into the standard taxonomy categories—it is neither an earnings release, M&A activity, executive change, nor a negative event like impairment or litigation. The disclosure of positive Phase 3 data would materially affect investor assessment of the company's pipeline prospects and regulatory pathway.

View raw filing on EDGAR →

GLOBAL TECH INDUSTRIES GROUP, INC.

8-K Other material confidence 75% filed 2026-05-26

The filing discloses a court-appointed receivership over the company (appointed September 18, 2024) and the filing of a Seventh Interim Report by the Receiver describing ongoing receivership activities, including resignation of the independent auditor, audit status issues for fiscal years 2023-2024, misappropriated funds, and pending litigation. While receivership is a terminal financial event, it does not fit neatly into the bankruptcy_filing category (which typically refers to formal bankruptcy proceedings under Chapter 7 or 11) nor any other specific taxonomy event. This is a material disclosure affecting investor assessment of the registrant's viability and control.

View raw filing on EDGAR →

Benchmark 2026-V22 Mortgage Trust

8-K Other material confidence 75% filed 2026-05-26 Item 8.01

This Item 8.01 discloses the closing of a commercial mortgage-backed securitization (CMBS) transaction on May 26, 2026, involving the issuance of approximately $729.9 million in certificates by Benchmark 2026-V22 Mortgage Trust. While the filing describes the transaction structure, underwriters, and credit risk retention arrangements under Regulation RR, it does not fit neatly into the standard 8-K event taxonomy. The disclosure is material to investors as it documents a significant securitization closing with multiple certificate classes and substantial principal amounts, but the event is best classified as "other_material" rather than a more specific category like ma_activity, since it represents the closing of a securitization vehicle rather than a traditional acquisition or disposition by the registrant itself.

View raw filing on EDGAR →

Progyny, Inc. (PGNY)

8-K Other material confidence 75% filed 2026-05-26 Item 8.01

The Board approved a $200 million share repurchase program, which is a material capital allocation decision affecting shareholder value and the company's financial position. While share repurchases are common corporate actions, a $200 million program represents a significant commitment of available cash and would affect a reasonable investor's assessment of capital strategy and financial flexibility. This does not fit neatly into the more specific event categories (it is not an earnings release, M&A activity, executive change, or financial restatement), making "other_material" the appropriate classification.

View raw filing on EDGAR →

Strive, Inc. (SATA)

8-K Other material confidence 75% filed 2026-05-26 Item 8.01

Strive announced a significant bitcoin purchase of 1,109 BTC at ~$76,989 per coin during May 19-22, 2026, along with material changes to its balance sheet composition (cash, bitcoin holdings, and equity issuances). The company also disclosed plans to refresh its ATM programs. While this reflects treasury management and asset allocation decisions rather than a discrete event type (M&A, litigation, restatement, etc.), the scale of the bitcoin acquisition and the resulting changes to shareholder equity structure would materially affect a reasonable investor's assessment of the company's financial position and strategy.

View raw filing on EDGAR →

Lincoln International, Inc. (LCLN)

8-K Other material confidence 45% filed 2026-05-26 Item 3.03

The company disclosed a material modification to rights of security holders, with the substance incorporated by reference from Item 5.03, relating to governance or capital structure changes affecting security holder rights.

View raw filing on EDGAR →

Federal Home Loan Bank of New York

8-K Other material confidence 65% filed 2026-05-26 Item 2.03

This Item 2.03 disclosure describes the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) by the Federal Home Loan Bank of New York. While the filing explicitly states "consolidated obligations issuance is material to the Bank," the disclosure is primarily informational and regulatory in nature—explaining the structure, joint and several liability framework, and reporting methodology for consolidated obligations rather than announcing a specific new debt issuance event. The absence of a Schedule A with specific issuance details and the emphasis on general policies and disclaimers suggest this is a routine periodic disclosure of the Bank's debt issuance program rather than a discrete material event triggering Item 2.03.

View raw filing on EDGAR →

BIO-PATH HOLDINGS, INC. (BPTH)

8-K Other material confidence 72% filed 2026-05-26 Item 8.1

The filing discloses two significant Board-approved actions: (1) launch of a digital asset treasury 2.0 program involving cryptocurrency trading and a Coinbase account, and (2) assignment to the Company of up to $10 million from a $57.9 million judgment awarded to CEO Vikram Grover against NSAV et al., with consideration to be paid in Company Notes, Preferred Stock, or Common Shares. While the judgment assignment could signal potential dilutive issuance or material litigation settlement, the disclosure centers on Board approval of strategic initiatives and a contingent asset acquisition rather than a completed transaction or traditional event type. The cryptocurrency treasury program and judgment monetization represent material strategic decisions affecting shareholder value, but do not fit cleanly into the standard taxonomy categories.

View raw filing on EDGAR →

DuPont de Nemours, Inc. (DD)

8-K Other material confidence 75% filed 2026-05-26 Item 7.01

The Board of Directors approved a 1-for-3 reverse stock split effective June 24, 2026, which directly affects share count and per-share metrics for all shareholders.

View raw filing on EDGAR →

Odyssey Health, Inc. (ODYY)

8-K Other material confidence 55% filed 2026-05-26 Item 1.01

Amendment No. 12 to a promissory note with LGH Investments, LLC extended the maturity date to September 30, 2026. The amendment to this debt obligation may signal refinancing pressure or financial stress, though it does not constitute a covenant breach or other terminal event.

View raw filing on EDGAR →

FOCUS UNIVERSAL INC. (FCUV)

8-K Other material confidence 72% filed 2026-05-26 Item 8.01

The filing discloses multiple capital transactions (Series B preferred conversion, redemption, and a $4M warrant offering with Armistice) undertaken to restore compliance with Nasdaq's $2.5M stockholders' equity listing requirement. While these transactions involve dilutive issuances and equity restructuring, the core disclosure centers on the company's efforts to maintain continued listing status and its assertion of current compliance with Nasdaq standards—a material governance and going-concern-adjacent matter that does not fit neatly into the dilutive_issuance category alone, as the primary event is the restoration of listing compliance rather than the issuance itself.

View raw filing on EDGAR →

Kiniksa Pharmaceuticals International, plc (KNSA)

8-K Other material confidence 72% filed 2026-05-26 Item 1.01

The Company entered into a deed of waiver with Baker Bros. Advisors LP restricting the Shareholders' ability to convert Class A1/B1 shares into Class A/B shares if doing so would result in beneficial ownership exceeding 49.9% of voting rights. While this is a material definitive agreement affecting shareholder rights and voting control, it does not fit cleanly into the M&A activity category (no acquisition, disposition, merger, or change of control is occurring) and is better classified as a structural governance arrangement that would affect investor assessment of control and dilution risk.

View raw filing on EDGAR →

Blue Owl Credit Income Corp.

8-K Other material confidence 75% filed 2026-05-26 Item 8.01

The company declared monthly distributions to shareholders across three share classes, reported the status of its continuous and private offerings, disclosed May 2026 public offering prices and NAV per share, and provided portfolio and leverage metrics as of April 30, 2026.

View raw filing on EDGAR →

Holley Inc. (HLLY-WT)

8-K Other material confidence 72% filed 2026-05-26 Item 8.01

The Board approved a $25 million share repurchase program, which is a material capital allocation decision that affects shareholder value and the company's financial position. While share repurchases are common corporate actions, a $25 million authorization is material to a reasonable investor's assessment of the company's capital strategy and financial health. This does not fit neatly into the more specific event categories (it is not a dilutive issuance, M&A activity, or executive compensation), making "other_material" the most appropriate classification.

View raw filing on EDGAR →

RYAN SPECIALTY HOLDINGS, INC. (RYAN)

8-K Other material confidence 72% filed 2026-05-26 Item 7.01

The disclosure announces Board approval of a $300 million increase to the Company's share repurchase program, bringing total authorization to $600 million. While share repurchase programs are capital allocation decisions that affect shareholder value and are material to investors, this event does not fit cleanly into the more specific taxonomy categories (it is not an earnings release, executive change, M&A activity, impairment, or other defined event type). The materiality stems from the significant capital commitment and signaling effect on management's confidence in the stock valuation.

View raw filing on EDGAR →

Blue Owl Technology Income Corp.

8-K Other material confidence 75% filed 2026-05-26 Item 8.01

The filing discloses routine monthly distribution declarations and ongoing offering status updates, along with material portfolio and leverage metrics including 155 portfolio companies, $5.0B par value, 0.82x net leverage, and $1.3B liquidity.

View raw filing on EDGAR →

D-Wave Quantum Inc. (QBTS)

8-K Other material confidence 72% filed 2026-05-26 Item 7.01

D-Wave announced second-year funding for the SQFab project awarded by the U.S. Department of War through NORDTECH, a regional defense technology hub. While this is a government contract award that could be material to investors assessing the company's revenue pipeline and strategic positioning in quantum computing for defense applications, it does not fit neatly into the more specific event categories (not an earnings release, M&A activity, executive change, or financial restatement). The disclosure emphasizes recognition of quantum computing's role in U.S. microelectronics innovation, suggesting competitive and strategic significance.

View raw filing on EDGAR →

D-Wave Quantum Inc. (QBTS)

8-K Other material confidence 65% filed 2026-05-26 Item 7.01

D-Wave issued a public response to scientific claims challenging its quantum computational supremacy demonstration, a core assertion underlying the company's technology and market positioning. While the disclosure is defensive in nature and filed under Item 7.01 (Regulation FD), the rebuttal of claims that would undermine the company's principal scientific achievement—if accepted by the market—could materially affect investor perception of D-Wave's competitive advantage and technology viability. This does not fit neatly into the standard taxonomy (not litigation, not a material impairment, not an earnings miss), making "other_material" the most appropriate classification.

View raw filing on EDGAR →

Golub Capital Private Income Fund I

8-K Other material confidence 75% filed 2026-05-26 Item 8.01

The Fund disclosed portfolio composition, NAV of $24.22 per share, debt-to-equity leverage of 1.24x, and portfolio fair value of $433 million as of April 30, 2026, providing material updates on fund performance and financial position.

View raw filing on EDGAR →

BALTIMORE GAS & ELECTRIC CO

8-K Other material confidence 65% filed 2026-05-22 Item 1.01

BGE issued $925 million in aggregate principal amount of senior notes ($500 million at 5.150% due 2033 and $425 million at 6.050% due 2056) to retire existing debt and fund general corporate purposes, creating a material direct financial obligation and affecting the company's capital structure.

View raw filing on EDGAR →

FIFTH THIRD BANCORP (FITBP)

8-K Other material confidence 72% filed 2026-05-22 Item 8.01

Fifth Third Bancorp announced early tender results for exchange offers involving up to $1.55 billion in debt refinancing (exchanging Comerica-originated notes for new Fifth Third notes plus cash). While this involves material debt restructuring activity, it does not fit cleanly into the standard taxonomy categories—it is neither a traditional M&A transaction (ma_activity), a covenant breach, nor a dilutive equity issuance. The disclosure of early tender results for a significant debt exchange is material to investors assessing the company's capital structure and financial position, warranting classification as other_material.

View raw filing on EDGAR →

FORD MOTOR CREDIT CO LLC

8-K Other material confidence 65% filed 2026-05-22 Item 8.01

Ford Motor Credit Company issued $1 billion in senior notes on May 22, 2026, a material debt issuance that affects the company's capital structure and financial obligations. While this is a significant financing event, it does not fit neatly into the more specific event categories (it is not M&A, a restatement, covenant breach, or other defined event types), making "other_material" the most appropriate classification for a material debt offering disclosed under Item 8.01.

View raw filing on EDGAR →

GEORGIA POWER CO (GPJA)

8-K Other material confidence 75% filed 2026-05-22 Item 8.01

Georgia Power entered into underwriting agreements on May 19, 2026 to issue $1.25 billion in aggregate principal amount of senior notes across three tranches ($150M Series 2025B, $600M Series 2026A floating rate, and $550M Series 2026B). This represents a material debt issuance that would affect investor assessment of the company's capital structure and financing activities, but does not fit the specific M&A or covenant-breach categories; it is disclosed under Item 8.01 (Other Events) rather than Item 2.01 (debt issuance), suggesting it is being treated as a material event outside the standard debt-offering framework.

View raw filing on EDGAR →

FIRST BUSEY CORP /NV/ (BUSEP)

8-K Other material confidence 72% filed 2026-05-22 Item 8.01

The board approved an amendment to increase the share repurchase authorization by 4,000,000 shares, bringing total authorized repurchases to 4,903,775 shares, signaling management's capital allocation priorities and confidence in the stock's valuation.

View raw filing on EDGAR →

DYNEX CAPITAL INC (DX-PC)

8-K Other material confidence 65% filed 2026-05-22 Item 5.03

Shareholders approved an amendment to the Company's Articles of Incorporation increasing authorized common shares from 360 million to 720 million, effective May 22, 2026, which is material to investors assessing potential dilution and capital structure.

View raw filing on EDGAR →

SOUTHERN CO GAS

8-K Other material confidence 75% filed 2026-05-22 Item 8.01

Southern Company Gas entered into an underwriting agreement for a $500 million issuance of junior subordinated notes due 2056, guaranteed by the parent company. While this is a material debt issuance that would affect investor assessment of the registrant's capital structure and leverage, it does not fit neatly into the more specific event categories (it is not M&A, a restatement, auditor change, going concern, impairment, delisting, bankruptcy, covenant breach, cybersecurity incident, or dilutive equity issuance). This is disclosed under Item 8.01 (Other Events) and represents a material financing event best classified as other_material.

View raw filing on EDGAR →

Enertopia Corp. (ENRT)

8-K Other material confidence 65% filed 2026-05-22 Item 7.01

The disclosure under Item 7.01 (Regulation FD Disclosure) announces a news release providing details of "proposed financing." While the exact nature of the financing is not fully specified in the Item text itself, proposed financing activity could encompass debt issuance, equity offerings, or other capital-raising mechanisms. Without more granular detail about whether this is a dilutive equity issuance (Item 3.02), a debt covenant matter, or another specific event type, and given that it is characterized as "proposed" rather than completed, this is best classified as other_material—a material financing announcement that does not fit neatly into the more specific taxonomy categories.

View raw filing on EDGAR →

UGI CORP /PA/ (UGI)

8-K Other material confidence 70% filed 2026-05-22 Item 2.03

UGI International issued €300 million in senior notes due 2031, creating a direct financial obligation. The proceeds were used for refinancing and general corporate purposes, with the notes carrying standard restrictive covenants and events of default typical of senior unsecured debt.

View raw filing on EDGAR →

Navitas Semiconductor Corp (NVTS)

8-K Other material confidence 72% filed 2026-05-22 Item 1.01

The filing discloses a Settlement, Release and Amendment Agreement between Navitas and Live Oak Sponsor Partners II regarding earnout shares from the 2021 business combination. The settlement involves transfer of 726,225 previously unvested earnout shares to Live Oak Sponsor, forfeiture of 115,775 shares, and mutual releases of claims. While this involves earnout mechanics from a prior M&A transaction, the core event is a settlement agreement resolving disputes—not the M&A activity itself (which occurred in 2021). This settlement is material as it resolves contingent equity obligations and disputes, but does not fit cleanly into ma_activity (no new acquisition/disposition), exec_compensation (not executive compensation), or dilutive_issuance (shares already contemplated in the 2021 deal). The event is best classified as other_material given its settlement nature and material impact on earnout obligations.

View raw filing on EDGAR →

BKV Corp (BKV)

8-K Other material confidence 75% filed 2026-05-22 Item 1.01

BKV entered into a Sixth Amendment to its reserve-based lending agreement on May 20, 2026, which relaxes key financial covenants by increasing maximum permitted net leverage ratios across restricted payments, debt prepayments, and permitted investments. While this is a material credit agreement amendment affecting the company's financial flexibility and covenant compliance, it does not fit cleanly into the more specific event categories (not an M&A activity, covenant breach, or dilutive issuance). The amendment signals potential financial stress or tightening liquidity, but the disclosure itself is of a covenant waiver/amendment rather than a breach or going-concern issue.

View raw filing on EDGAR →

PEPSICO INC (PEP)

8-K Other material confidence 75% filed 2026-05-22 Item 8.01

PepsiCo terminated and replaced two material credit facilities totaling $10 billion ($5B 364-day and $5B five-year revolving credit agreements). While routine credit facility renewals are common, the disclosure of these $5 billion facilities and their replacement terms is material to investors assessing the company's liquidity and financing capacity. This does not fit neatly into the more specific event categories (not a covenant breach, not a going-concern issue, not M&A activity), making "other_material" the most appropriate classification.

View raw filing on EDGAR →

FEDEX CORP (FDX)

8-K Other material confidence 75% filed 2026-05-22 Item 8.01

FedEx announced the full redemption of €354.9 million in 1.300% Notes due 2031, with a redemption price of €358.6 million (including accrued interest) payable on May 28, 2026. This is a material debt management event affecting the company's capital structure and liquidity, but does not fit neatly into the more specific event categories (it is neither a covenant breach, dilutive issuance, nor M&A activity). The redemption represents a significant financial obligation and refinancing decision material to investors.

View raw filing on EDGAR →

MOLSON COORS BEVERAGE CO (TAP-A)

8-K Other material confidence 75% filed 2026-05-22 Item 8.01

Molson Coors disclosed the entry into underwriting and purchase agreements for $1.5 billion in aggregate principal amount of senior notes ($500M USD 4.900% due 2031, $1.0B USD 5.500% due 2036, and C$500M CAD 4.300% due 2033). While debt issuance is material to investors, it does not fit neatly into the specific event categories (not M&A, not a restatement, not a covenant breach, etc.). This is a material financing event that would affect investor assessment of the company's capital structure and liquidity, warranting classification as other_material.

View raw filing on EDGAR →